Late Hypersensitivity Reactions to the BNT162b2 SARS-CoV-2 Vaccine Are Linked to Delayed Skin Sensitization and Prior Exposure to Hyaluronic Acid
Open Access
Abstract
Background: Late hypersensitivity reactions (HSRs) to the BNT162b2-vaccine have raised concerns regarding its safety, particularly as further immunizations are required. The yield of skin testing with the BNT162b2v is unclear, as well as the risk factors and outcomes of re-immunization after late HSRs. Objective: We studied a series of patients with late HSRs to BNT162b2v. Methods: Patients referred to the Sheba medical center from December 2020 to May 2021 with late HSRs to the first dose of BNT162b2 were included. HSRs were defined as late if they appeared or lasted >24 h after inoculation. We compared late HSRs to immediate HSRs that appeared within minutes–2 h after vaccination. Intradermal testing with PEG-containing medication and BNT162b2v was performed. Results: A total of 17 patients that presented with late HSRs (study group) were compared to 34 patients with immediate HSRs (control group). Delayed sensitivity to intradermal testing of the BNT162b2v was observed in 9/17 (53%) of the study group compared to 4/34 (12%) in the control group (p = 0.01). Former exposure to a dermal filler with hyaluronic acid was documented among 7/17 (41%) vs. 2/34 (6%) in the study and control groups, respectively, (p = 0.0038). All patients who presented with late HSRs were advised to receive subsequent doses of the BNT162b2v vaccine with or without concomitant medication, and all were re-immunized successfully. Conclusions: Late HSRs to BNT162b2v were linked with positive responses to intradermal testing with the vaccine and prior exposure to derma fillers with hyaluronic acid. This may elude to an immune mechanism triggered by former exposures. Although further studies are needed, late HSRs to the BNT162b2-vaccine did not prevent patients from receiving subsequent doses of the vaccines.Keywords
This publication has 38 references indexed in Scilit:
- Clinical Phenotypes of Severe Cutaneous Drug Hypersensitivity ReactionsCurrent Pharmaceutical Design, 2019
- A Systematic Review of the Literature of Delayed Inflammatory Reactions After Hyaluronic Acid Filler Injection to Estimate the Incidence of Delayed Type Hypersensitivity ReactionAesthetic Surgery Journal, 2019
- Delayed hypersensitivity reaction to hyaluronic acid dermal filler following influenza-like illnessClinical, Cosmetic and Investigational Dermatology, 2019
- Prevalence of contact allergy in the general population: A systematic review and meta‐analysisContact Dermatitis, 2018
- Late-Onset Inflammatory Response to Hyaluronic Acid Dermal FillersPlastic and Reconstructive Surgery - Global Open, 2017
- Polyethylene glycol as marker for nitrofurazone allergy: 20 years of experience from TurkeyContact Dermatitis, 2017
- Analysis of Pre-existing IgG and IgM Antibodies against Polyethylene Glycol (PEG) in the General PopulationAnalytical Chemistry, 2016
- Delayed immune mediated adverse effects to hyaluronic acid fillers: report of five cases and review of the literatureDermatology Reports, 2015
- Poly(ethylene glycol) in Drug Delivery: Pros and Cons as Well as Potential AlternativesAngewandte Chemie International Edition, 2010
- Contact allergy to EDTA in a topical corticosteroid preparationContact Dermatitis, 1986